Soleno Therapeutics, Inc. (SLNO) NASDAQ

87.42

+2.55(+3.00%)

Updated at July 31 12:42PM

Currency In USD

Valuation

Market Cap1.81B
Enterprise Value1.77B
P/E Ratio-19.77
PEG Ratio2.34
Price/Sales Ratio0
Price/Book Ratio16.87
Enterprise/Revenue0
Enterprise/EBITDA-28.04

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterMarch 31, 2025

Profitability

Profit Margin0
Operating Margin0

Management Effectiveness

Return On Assets-0.62
Return On Equity-0.78

Income Statement

Revenue0
Revenue/Share0
Gross Profit0
EBITDA-173.63M
Net Income-175.85M
Diluted EPS-4.38

Balance Sheet

Total Cash289.95M
Total Cash/Share6.28
Total Debt52.79M
Total Debt/Equity0.01
Current Ratio19.64
Book Value Per Share5.03

Price History

52-Week Change75.96
52-Week High90.32
52-Week Low41.5
Moving Average 50 Days81.24
Moving Average 200 Days61.61

Statistics

Average Volume1.06M
Shares Outstanding52.75M
% Held by Institutions116.59

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor1:15
Last Split DateAugust 26, 2022